National Effort to Hasten Treatments for Those With Pancreatic Cancer Enrolling Patients at UF Health

A novel clinical trial platform that aims to accelerate treatment discoveries for people battling pancreatic cancer is now enrolling patients at 15 sites nationwide, including the University of Florida Health Cancer Center. An initiative of the national nonprofit organization Pancreatic Cancer Action Network, or PanCAN, Precision PromiseSM began development in 2016. The UF Health Cancer Center is the […]

Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101

UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, announced receipt of Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its lead product, SBP-101, being developed for first-line treatment of patients with metastatic pancreatic ductal adenocarcinoma (PDA) when administered in […]